Novel control of MT5-MMP on amyloidogenic and inflammatory pathways: validation in human iPSCs from Alzheimer patients and potential therapeutic perspectives – COEN3030
Monsieur Santiago Rivera (DHUNE)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Help of the ANR 186,000 euros
Beginning and duration of the scientific project: February 2016 - 24 Months